EBS Emergent BioSolutions Inc. Common Stock
EBS 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
EBS 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
EBS 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
- 적극 매수 1 16.7%
- 매수 4 66.7%
- 보유 1 16.7%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
2 명의 애널리스트 · 2026-08-17실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $0.60 | $0.11 | 0.49% |
| 2026년 3월 31일 | $0.21 | $-0.25 | 0.46% |
| 2025년 12월 31일 | $-0.43 | $0.11 | -0.54% |
| 2025년 9월 30일 | $1.06 | $-0.12 | 1.2% |
| 2025년 6월 30일 | $0.16 | $-0.49 | 0.65% |
| 2025년 3월 31일 | $0.71 | $0.44 | 0.27% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | — |
| GLSI | $300M | -14.7 | — | — | -2159.7% | — |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | — |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | — |
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 18
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $743M | $1.04B | $1.05B | $1.12B | $1.77B | $1.58B | $1.11B | $782M | $561M | $489M | $489M | $404M | |
| Cost of Revenue | $326M | $681M | $705M | $693M | $748M | $537M | $434M | $322M | $188M | $126M | $107M | $102M | |
| Gross Profit | · | · | $318M | $383M | $891M | $925M | · | · | · | · | · | · | |
| R&D Expense | $53M | $71M | $111M | $188M | $235M | $238M | $226M | $143M | $97M | $107M | $119M | $105M | |
| SG&A Expense | $186M | $308M | $368M | $340M | $349M | $304M | $274M | $202M | $143M | $143M | $121M | $109M | |
| Operating Expenses | · | · | · | · | · | · | $992M | $693M | $437M | $383M | · | · | |
| Operating Income | $100M | $-109M | $-726M | $-170M | $341M | $438M | $114M | $90M | $124M | $106M | $142M | $89M | |
| Interest Expense | · | · | $88M | $37M | $34M | $31M | $38M | $10M | $7M | $8M | $7M | $8M | |
| Interest Income | · | · | · | · | · | · | · | · | $2M | $1M | $572.0K | $320.0K | |
| Other Non-op | $54M | $12M | $6M | $-12M | $-4M | $5M | $2M | $2M | $900.0K | $1M | $153.0K | $3M | |
| Pretax Income | $83M | $-143M | $-731M | $-219M | $303M | $412M | $77M | $82M | $119M | $99M | $136M | $84M | |
| Income Tax | $30M | $48M | $29M | $-7M | $84M | $106M | $23M | $19M | $36M | $37M | $44M | $30M | |
| Net Income | $53M | $-191M | $-760M | $-212M | $220M | $306M | $54M | $63M | $83M | $52M | $63M | $37M | |
| EPS (Basic) | $0.98 | $-3.60 | $-14.85 | $-4.22 | $4.10 | $5.80 | $1.06 | $1.25 | $1.98 | $1.29 | $1.63 | $0.98 | |
| EPS (Diluted) | $0.93 | $-3.60 | $-14.85 | $-4.22 | $4.06 | $5.68 | $1.04 | $1.22 | $1.71 | $1.13 | $1.41 | $0.88 | |
| Shares (Basic) | 53,500,000 | 53,000,000 | 51,200,000 | 50,100,000 | 53,500,000 | 52,700,000 | 51,500,000 | 50,100,000 | 41,800,000 | 40,200,000 | 38,595,435 | 37,344,891 | |
| Shares (Diluted) | 56,700,000 | 53,000,000 | 51,200,000 | 50,100,000 | 54,100,000 | 53,800,000 | 52,400,000 | 51,400,000 | 50,300,000 | 49,300,000 | 47,255,842 | 45,802,807 | |
| EBITDA | $196M | $100.0K | $-601M | $-170M | $353M | $484M | $164M | $126M | $157M | $134M | $121M | $81M |
대차대조표 30
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $100M | $112M | $643M | $576M | $621M | $168M | $112M | $178M | $272M | $313M | $280M | |
| Receivables | $84M | $154M | $191M | $159M | $279M | $231M | $271M | $262M | $144M | $138M | $114M | $59M | |
| Inventory | $343M | $312M | $329M | $351M | $344M | $307M | $222M | $206M | $143M | $74M | $61M | $66M | |
| Prepaid Expense | $26M | $27M | $48M | $58M | $70M | $36M | $25M | $32M | $17M | $16M | $18M | $24M | |
| Current Assets | $662M | $599M | $680M | $1.21B | $1.27B | $1.20B | $686M | $621M | $485M | $510M | $537M | $432M | |
| PP&E (Net) | $205M | $271M | $383M | $818M | $800M | $644M | $542M | $510M | $407M | $376M | $328M | $314M | |
| PP&E (Gross) | $510M | $668M | $794M | $1.20B | $1.12B | $903M | $753M | $682M | $540M | $488M | $422M | $393M | |
| Accum. Depreciation | $304M | $397M | $411M | $384M | $319M | $259M | $210M | $172M | $132M | $112M | $94M | $79M | |
| Goodwill | $0 | $0 | $0 | $218M | $225M | $267M | $267M | $260M | $49M | $41M | $41M | $53M | |
| Intangibles | $436M | $502M | $567M | $729M | $605M | $663M | $713M | $762M | $120M | $34M | $41M | $58M | |
| Other Non-current Assets | $14M | $19M | $194M | $191M | $58M | $113M | $90M | $14M | $6M | $2M | $2M | $8M | |
| Total Assets | $1.32B | $1.39B | $1.82B | $3.17B | $2.96B | $2.88B | $2.33B | $2.23B | $1.07B | $970M | $1.04B | $939M | |
| Accounts Payable | $56M | $61M | $112M | $104M | $129M | $136M | $95M | $81M | $42M | $35M | $38M | $41M | |
| Accrued Liabilities | $12M | $18M | $19M | $35M | $52M | $47M | $40M | $31M | $5M | $6M | $6M | $6M | |
| Short-term Debt | · | $0 | $414M | $957M | $32M | $34M | $13M | $10M | $0 | $20M | $0 | · | |
| Current Liabilities | $132M | $162M | $651M | $1.23B | $374M | $384M | $216M | $200M | $100M | $106M | $100M | $93M | |
| Capital Leases | $9M | $10M | $14M | $15M | $24M | $28M | $22M | · | · | · | · | · | |
| Deferred Tax | $38M | $42M | $47M | $60M | $93M | $53M | $64M | $68M | $0 | · | · | · | |
| Other Non-current Liabilities | $54M | $39M | $29M | $42M | $70M | $68M | $49M | $49M | $5M | $2M | $1M | $1M | |
| Total Liabilities | $796M | $907M | $1.17B | $1.78B | $1.35B | $1.44B | $1.24B | $1.22B | $158M | $374M | $377M | $385M | |
| Long-term Debt | $590M | $700M | $868M | $1.41B | $850M | $886M | $822M | $809M | $14M | · | · | · | |
| Total Debt | $572M | $664M | $1.27B | · | $873M | $909M | $824M | $805M | $13M | $268M | $253M | $251M | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $41.0K | $40.0K | $38.0K | |
| Paid-in Capital | $942M | $928M | $904M | $874M | $829M | $785M | $716M | $689M | $618M | $352M | $318M | $274M | |
| Retained Earnings | $-160M | $-212M | $-22M | $739M | $950M | $727M | $422M | $367M | $337M | $254M | $351M | $288M | |
| Treasury Stock | $253M | $228M | $228M | $228M | $152M | $40M | $40M | $40M | $40M | $6M | $6M | $6M | |
| AOCI | $-8M | $-5M | $-6M | $3M | $-16M | $-25M | $-10M | $-6M | $-4M | $-4M | $-3M | $-3M | |
| Stockholders' Equity | $523M | $483M | $649M | $1.39B | $1.61B | $1.45B | $1.09B | $1.01B | $912M | $596M | $660M | $553M | |
| Liabilities + Equity | $1.32B | $1.39B | $1.82B | $3.17B | $2.96B | $2.88B | $2.33B | $2.23B | $1.07B | $970M | $1.04B | $939M | |
| Shares Outstanding | 52,100,000 | 54,300,000 | 52,200,000 | 50,100,000 | 51,300,000 | 54,300,000 | 51,700,000 | 51,200,000 | 49,400,000 | 41,000,000 | 39,800,000 | 38,129,872 |
현금 흐름 19
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $96M | $109M | $125M | $143M | $124M | $50M | $50M | $36M | $32M | $28M | $24M | $22M | |
| Stock-based Comp | $16M | $18M | $23M | $45M | $42M | $52M | $27M | $23M | $15M | $18M | $16M | $13M | |
| Deferred Tax | $-4M | $-6M | $-7M | $-34M | $43M | $-3M | $-1M | $9M | $3M | $5M | $3M | $16M | |
| Amort. of Intangibles | $65M | $65M | $66M | $60M | $58M | $60M | $59M | $25M | $9M | $7M | $7M | $7M | |
| Restructuring | $-2M | $22M | $29M | · | · | · | · | · | · | · | · | $0 | |
| Other Non-cash | $10M | $128M | $413M | · | · | $132M | $58M | $-89M | $75M | $-50M | $-62M | $23M | |
| Operating Cash Flow | $171M | $59M | $-206M | $-34M | $320M | $537M | $188M | $42M | $208M | $55M | $43M | $112M | |
| CapEx | $14M | $23M | $52M | $116M | $224M | $142M | $87M | $72M | $55M | $76M | $45M | $31M | |
| Investing Cash Flow | $69M | $125M | $212M | $-381M | $-224M | $-152M | $-97M | $-897M | $-250M | $-76M | $-45M | $-210M | |
| Debt Issued | · | · | · | · | · | · | · | $798M | $0 | $0 | $2M | $1M | |
| Net Debt Issued | · | · | · | · | · | · | · | $795M | $0 | $0 | $0 | $-62M | |
| Stock Issued | $0 | $0 | $8M | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $25M | $0 | $0 | $82M | $106M | $0 | $0 | $100.0K | $33M | $0 | $100.0K | $200.0K | |
| Net Stock Activity | $-25M | $0 | $8M | $-82M | $-106M | $0 | $0 | $-100.0K | $-33M | $0 | $-100.0K | $-200.0K | |
| Financing Cash Flow | $-137M | $-190M | $-536M | $481M | $-141M | $70M | $-36M | $789M | $-51M | $-20M | $35M | $199M | |
| Net Change in Cash | $104M | $-6M | $-531M | $66M | $-45M | $454M | $56M | $-67M | $-93M | $-41M | $32M | $101M | |
| Taxes Paid | $40M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $157M | $36M | $-258M | $-150M | $96M | $395M | $101M | $-30M | $153M | $-23M | $-353.0K | $82M | |
| Levered FCF | · | · | $-349M | $-186M | $71M | $372M | $74M | $-38M | $149M | $-28M | $-5M | $76M |
수익성 8
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 30.3% | 34.3% | · | · | · | · | · | · | · | · | |
| Operating Margin | 13.5% | -10.4% | -69.2% | -15.2% | 19.7% | 27.9% | 10.3% | 11.5% | 22.2% | 21.6% | 18.4% | 12.9% | |
| Net Margin | 7.1% | -18.3% | -72.5% | -18.9% | 12.9% | 19.6% | 4.9% | 8.0% | 14.7% | 10.6% | 12.0% | 8.2% | |
| Pretax Margin | 11.2% | -13.7% | -69.7% | -19.6% | 17.5% | 26.2% | 7.0% | 10.4% | 21.1% | 20.3% | 17.2% | 11.8% | |
| EBITDA Margin | 26.4% | 0.01% | -57.3% | -15.2% | 19.7% | 31.1% | 14.8% | 16.1% | 27.9% | 27.3% | 23.1% | 18.0% | |
| ROA | 3.9% | -11.9% | -30.5% | · | 7.9% | 11.7% | 2.4% | 3.8% | 8.1% | 5.2% | 6.4% | 4.7% | |
| ROE | 9.9% | -38.5% | -113.0% | · | 14.7% | 22.6% | 5.1% | 6.3% | 10.9% | 8.2% | 10.4% | 7.0% | |
| ROIC | 5.8% | -12.7% | -39.3% | · | 10.4% | 13.8% | 4.2% | 3.8% | 9.3% | 7.7% | 7.4% | 5.0% |
유동성 및 지급능력 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 3.7 | 1.0 | · | 3.4 | 3.1 | 3.2 | 3.1 | 4.9 | 4.8 | 5.4 | 4.7 | |
| Quick Ratio | 2.2 | 1.6 | 0.5 | · | 2.3 | 2.2 | 2.0 | 1.9 | 3.2 | 3.9 | 4.4 | 3.7 | |
| Debt / Equity | 1.1 | 1.4 | 2.0 | · | 0.5 | 0.6 | 0.8 | 0.8 | 0.0 | 0.4 | 0.4 | 0.5 | |
| LT Debt / Equity | 1.1 | 1.4 | 0.7 | · | 0.5 | 0.6 | 0.7 | 0.8 | 0.0 | 0.4 | 0.4 | 0.5 | |
| Interest Coverage | · | · | -8.3 | -4.6 | 10.2 | 13.9 | 3.0 | 9.1 | 18.9 | 13.9 | 14.7 | 7.0 |
효율성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.6 | 0.4 | · | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | |
| Inventory Turnover | 1.0 | · | 2.1 | · | · | 2.0 | 2.0 | 1.8 | 1.8 | 1.9 | 1.7 | 2.9 | |
| Receivables Turnover | 6.2 | 6.0 | 6.0 | · | 7.1 | 6.2 | 4.1 | 3.9 | 4.0 | 3.9 | 5.8 | 7.5 |
성장률 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -28.8% | -0.54% | -6.1% | -37.0% | 12.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -12.7% | -16.2% | -12.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -14.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | -28.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -30.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | -28.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -29.7% | · | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $743M | $1.04B | $1.05B | $1.12B | $1.77B | $1.58B | $1.11B | $782M | $561M | $489M | $489M | $404M | |
| Net Income TTM | $53M | $-191M | $-760M | $-212M | $220M | $306M | $54M | $63M | $83M | $52M | $63M | $37M | |
| Market Cap | $644M | $519M | $125M | · | $2.23B | $4.76B | $2.79B | $3.04B | $2.30B | $1.33B | $1.58B | $1.03B | |
| Enterprise Value | $1.01B | $1.08B | $1.29B | · | $2.53B | $5.05B | $3.45B | $3.73B | $2.13B | $1.33B | $1.52B | $997M | |
| P/E | 13.3 | -2.7 | -0.2 | -2.8 | 10.7 | 15.8 | 51.9 | 48.6 | 27.2 | 29.1 | 28.4 | 30.9 | |
| P/S | 0.9 | 0.5 | 0.1 | · | 1.3 | 3.0 | 2.5 | 3.9 | 4.1 | 2.7 | 3.2 | 2.5 | |
| P/B | 1.2 | 1.1 | 0.2 | · | 1.4 | 3.3 | 2.6 | 3.0 | 2.5 | 2.2 | 2.4 | 1.9 | |
| P / Tangible Book | 7.5 | · | 1.5 | 1.3 | 2.9 | 9.1 | · | · | · | · | · | · | |
| P / Cash Flow | 3.8 | 8.8 | -0.6 | · | 6.9 | 8.9 | 14.8 | 72.6 | 11.0 | 24.9 | 35.5 | 9.1 | |
| P / FCF | 4.1 | 14.5 | -0.5 | · | 23.2 | 12.0 | 27.6 | -100.2 | 15.0 | -58.5 | -4466.5 | 12.6 | |
| EV / EBITDA | 5.2 | 10833.1 | -2.1 | · | 7.2 | 10.4 | 21.1 | 29.6 | 13.6 | 10.0 | 12.6 | 12.3 | |
| EV / FCF | 6.4 | 30.3 | -5.0 | · | 26.3 | 12.8 | 34.1 | -123.0 | 13.9 | -58.4 | -4297.1 | 12.2 | |
| EV / Revenue | 1.4 | 1.0 | 1.2 | · | 1.4 | 3.2 | 3.1 | 4.8 | 3.8 | 2.7 | 3.1 | 2.5 | |
| Earnings Yield | 7.5% | -37.7% | -618.8% | -35.7% | 9.3% | 6.3% | 1.9% | 2.1% | 3.7% | 3.4% | 3.5% | 3.2% |
손익계산서 16
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $234M | $156M | $149M | $231M | $141M | $222M | $195M | $294M | $255M | $300M | $277M | $270M | $338M | $164M | $330M | $240M | |
| Cost of Revenue | $97M | $72M | $85M | $86M | $67M | $88M | $118M | $123M | $296M | $145M | $185M | $177M | $191M | $153M | · | $147M | |
| Gross Profit | · | · | · | · | · | · | · | $161M | $-48M | $148M | · | $87M | $141M | $5M | · | $75M | |
| R&D Expense | $9M | $10M | $12M | $14M | $12M | $15M | $9M | $14M | $33M | $15M | $29M | $15M | $26M | $41M | $50M | $42M | |
| SG&A Expense | $45M | $47M | $51M | $39M | $44M | $52M | $61M | $77M | $86M | $85M | $90M | $86M | $91M | $101M | $92M | $82M | |
| Operating Income | $-125M | $10M | $-28M | $76M | $2M | $50M | $-10M | $64M | $-204M | $40M | $-44M | $-242M | $-293M | $-148M | $-55M | $-45M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $24M | · | $20M | $29M | $18M | · | $8M | |
| Other Non-op | $0 | $14M | $-8M | $-4M | $-4M | $70M | $-4M | $22M | $-3M | $-3M | $8M | $-3M | $-4M | $5M | $7M | $-13M | |
| Pretax Income | $-166M | $13M | $-51M | $58M | $-17M | $93M | $-28M | $142M | $-270M | $12M | $-54M | $-266M | $-250M | $-161M | $-65M | $-67M | |
| Income Tax | $14M | $7M | $4M | $6M | $-5M | $25M | $4M | $28M | $13M | $3M | $-5M | $-2M | $11M | $26M | $-800.0K | $20M | |
| Net Income | $-180M | $7M | $-55M | $51M | $-12M | $68M | $-31M | $115M | $-283M | $9M | $-50M | $-263M | $-261M | $-186M | $-67M | $-87M | |
| EPS (Basic) | $-3.49 | $0.13 | $-1.01 | $0.96 | $-0.22 | $1.25 | $-0.55 | $2.16 | $-5.38 | $0.17 | $-0.90 | $-5.08 | $-5.16 | $-3.71 | $-1.32 | $-1.75 | |
| EPS (Diluted) | $-3.49 | $0.07 | $-0.95 | $0.91 | $-0.22 | $1.19 | $-0.45 | $2.06 | $-5.38 | $0.17 | $-0.90 | $-5.08 | $-5.16 | $-3.71 | $-1.32 | $-1.75 | |
| Shares (Basic) | 51,600,000 | 51,900,000 | -108,300,000 | 53,200,000 | 54,200,000 | 54,400,000 | -104,900,000 | 53,100,000 | 52,600,000 | 52,200,000 | -101,500,000 | 51,800,000 | 50,700,000 | 50,200,000 | -100,500,000 | 49,900,000 | |
| Shares (Diluted) | 51,600,000 | 56,500,000 | -111,300,000 | 56,500,000 | 54,200,000 | 57,300,000 | -107,400,000 | 55,600,000 | 52,600,000 | 52,200,000 | -101,500,000 | 51,800,000 | 50,700,000 | 50,200,000 | -100,500,000 | 49,900,000 | |
| EBITDA | $-125M | $34M | · | $76M | $2M | $75M | · | $64M | $-204M | $68M | · | $-242M | $-293M | $-114M | · | $-42M |
대차대조표 30
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $140M | $160M | $205M | $246M | $267M | $149M | $100M | $150M | $70M | $78M | $112M | $88M | $89M | $430M | $643M | $241M | |
| Receivables | $190M | $122M | $84M | $150M | $80M | $204M | $154M | $121M | $196M | $234M | · | $216M | $290M | $156M | · | $191M | |
| Inventory | $304M | $328M | $343M | $356M | $339M | $314M | $312M | $323M | $318M | $333M | · | $354M | $354M | $368M | · | $546M | |
| Prepaid Expense | $25M | $27M | $26M | $26M | $24M | $30M | $27M | $61M | $36M | $36M | · | $62M | $45M | $42M | · | $140M | |
| Current Assets | $666M | $638M | $662M | $787M | $720M | $707M | $599M | $661M | $654M | $682M | · | $721M | $778M | $1.22B | · | $1.12B | |
| PP&E (Net) | $178M | $199M | $205M | $210M | $216M | $221M | $271M | $278M | $306M | $379M | · | $395M | $396M | $717M | · | $807M | |
| PP&E (Gross) | $475M | $509M | $510M | $500M | $516M | $518M | $668M | $672M | $707M | $802M | · | $796M | $787M | $1.09B | · | $1.17B | |
| Accum. Depreciation | $297M | $310M | $304M | $291M | $300M | $297M | $397M | $394M | $401M | $423M | · | $401M | $391M | $375M | · | $366M | |
| Goodwill | · | · | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $218M | $218M | · | $225M | |
| Intangibles | $262M | $470M | $436M | $453M | $469M | $485M | $502M | $518M | $534M | $550M | · | $583M | $593M | $609M | · | $723M | |
| Other Non-current Assets | $11M | $13M | $14M | $12M | $12M | $13M | $19M | $20M | $19M | $191M | · | $194M | $195M | $185M | · | $36M | |
| Total Assets | $1.12B | $1.32B | $1.32B | $1.46B | $1.42B | $1.43B | $1.39B | $1.48B | $1.51B | $1.80B | · | $1.89B | $2.18B | $2.95B | · | $2.91B | |
| Accounts Payable | $50M | $40M | $56M | $57M | $64M | $58M | $61M | $82M | $96M | $100M | · | $113M | $108M | $124M | · | $104M | |
| Accrued Liabilities | $17M | $9M | $12M | $14M | $14M | $13M | $18M | $16M | $17M | $14M | · | $17M | $31M | $21M | · | $36M | |
| Short-term Debt | · | · | · | · | · | · | · | $800.0K | $415M | $459M | · | $414M | $455M | $951M | · | $21M | |
| Current Liabilities | $123M | $149M | $132M | $136M | $127M | $112M | $162M | $230M | $620M | $630M | · | $664M | $693M | $1.22B | · | $268M | |
| Capital Leases | $5M | $9M | $9M | $6M | $6M | $5M | $10M | $11M | $12M | $13M | · | $15M | $13M | $13M | · | $16M | |
| Deferred Tax | $35M | $33M | $38M | $36M | $46M | $60M | $42M | $42M | $35M | $35M | · | $52M | $58M | $60M | · | $114M | |
| Other Non-current Liabilities | $35M | $42M | $54M | $43M | $40M | $35M | $39M | $36M | $26M | $28M | · | $31M | $23M | $24M | · | $45M | |
| Total Liabilities | $775M | $797M | $796M | $878M | $881M | $873M | $907M | $969M | $1.13B | $1.14B | · | $1.20B | $1.22B | $1.75B | · | $1.46B | |
| Long-term Debt | $590M | $590M | $590M | $693M | $700M | $700M | $700M | $701M | $864M | $909M | · | $866M | $909M | $1.41B | · | $1.06B | |
| Total Debt | $582M | $574M | · | $663M | $668M | $666M | · | $663M | $1.28B | $1.37B | · | $1.28B | $1.36B | $2.35B | · | $1.07B | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| Paid-in Capital | $952M | $944M | $942M | $939M | $935M | $931M | $928M | $924M | $915M | $910M | · | $900M | $896M | $878M | · | $860M | |
| Retained Earnings | $-333M | $-153M | $-160M | $-105M | $-156M | $-144M | $-212M | $-181M | $-296M | $-13M | · | $28M | $290M | $551M | · | $822M | |
| Treasury Stock | $270M | $262M | $253M | $244M | $235M | $228M | $228M | $228M | $228M | $228M | · | $228M | $228M | $228M | · | $228M | |
| AOCI | $-7M | $-7M | $-8M | $-8M | $-8M | $-6M | $-5M | $-7M | $-6M | $-6M | · | $-3M | $-2M | $1M | · | $-5M | |
| Stockholders' Equity | $341M | $523M | $523M | $582M | $536M | $553M | $483M | $508M | $386M | $664M | $649M | $697M | $956M | $1.20B | $1.39B | $1.45B | |
| Liabilities + Equity | $1.12B | $1.32B | $1.32B | $1.46B | $1.42B | $1.43B | $1.39B | $1.48B | $1.51B | $1.80B | · | $1.89B | $2.18B | $2.95B | · | $2.91B | |
| Shares Outstanding | 51,300,000 | 51,800,000 | 52,100,000 | 52,700,000 | 53,700,000 | 54,500,000 | 54,300,000 | 54,100,000 | 52,900,000 | 52,400,000 | · | 51,800,000 | 51,800,000 | 50,400,000 | · | 49,900,000 |
현금 흐름 16
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24M | $24M | $24M | $23M | $24M | $25M | $26M | $26M | $28M | $28M | $30M | $28M | $33M | $35M | $36M | $32M | |
| Stock-based Comp | $7M | $2M | $5M | $5M | $5M | $2M | $4M | $2M | $6M | $6M | $4M | $4M | $8M | $7M | $12M | $11M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-57M | $20M | |
| Amort. of Intangibles | $17M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $17M | $18M | $14M | |
| Restructuring | · | · | $0 | $300.0K | $-1M | $-1M | $-400.0K | $6M | $17M | $-500.0K | $-600.0K | $20M | $-100.0K | $10M | · | · | |
| Other Non-cash | · | $-66M | · | · | · | $-106M | · | · | · | $-105M | · | · | · | $-42M | · | · | |
| Operating Cash Flow | $56M | $-34M | $78M | $-2M | $106M | $-11M | $-80M | $154M | $48M | $-63M | $32M | $60M | $-114M | $-184M | $93M | $-74M | |
| CapEx | $2M | $2M | $4M | $3M | $3M | $4M | $2M | $6M | $5M | $11M | $11M | $13M | $12M | $15M | $24M | $28M | |
| Investing Cash Flow | $-52M | $-2M | $-4M | $-3M | $17M | $60M | $29M | $112M | $-5M | $-11M | $-11M | $-19M | $258M | $-15M | $-45M | $-272M | |
| Stock Issued | · | $400.0K | $-1M | · | · | $0 | $0 | $0 | · | · | $200.0K | $0 | · | · | $0 | $0 | |
| Stock Repurchased | $9M | $9M | $9M | $9M | $7M | $0 | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $200.0K | $0 | |
| Net Stock Activity | · | $-9M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-24M | $-11M | $-114M | $-16M | $-6M | $-400.0K | $500.0K | $-180M | $-51M | $41M | $5M | $-43M | $-487M | $-10M | $353M | $229M | |
| Net Change in Cash | $-21M | $-48M | $-40M | $-22M | $118M | $47M | $-51M | $85M | $-8M | $-33M | $24M | $-800.0K | $-344M | $-210M | $402M | $-117M | |
| Free Cash Flow | · | $-36M | · | · | · | $-15M | · | · | · | $-73M | · | · | · | $-199M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-91M | · | · | · | $-219M | · | · |
수익성 8
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 54.9% | -18.9% | 49.2% | · | 32.2% | 41.6% | 2.1% | · | 30.8% | |
| Operating Margin | -53.4% | 6.7% | · | 33.1% | 1.1% | 22.5% | · | 21.9% | -79.9% | 13.2% | · | -89.5% | -86.7% | -89.7% | · | -17.5% | |
| Net Margin | -76.9% | 4.4% | · | 22.1% | -8.5% | 30.6% | · | 39.1% | -111.1% | 3.0% | · | -97.4% | -77.3% | -110.8% | · | -31.5% | |
| Pretax Margin | -71.0% | 8.6% | · | 24.9% | -11.9% | 41.7% | · | 48.5% | -105.9% | 4.0% | · | -98.3% | -74.1% | -97.6% | · | -26.6% | |
| EBITDA Margin | -53.4% | 21.8% | · | 33.1% | 1.1% | 33.9% | · | 21.9% | -79.9% | 22.5% | · | -89.5% | -86.7% | -68.8% | · | -17.5% | |
| ROA | -14.2% | 0.50% | · | 3.5% | -0.82% | 4.2% | · | 6.8% | -15.3% | 0.38% | · | -11.0% | -10.6% | -6.4% | · | -2.6% | |
| ROE | -41.1% | 1.3% | · | 9.4% | -2.6% | 11.2% | · | 19.0% | -42.2% | 0.96% | · | -24.5% | -21.2% | -13.2% | · | -5.1% | |
| ROIC | -14.7% | 0.49% | · | 5.5% | 0.09% | 3.0% | · | 4.4% | -12.8% | 1.5% | · | -12.2% | -13.2% | -4.7% | · | -2.0% |
유동성 및 지급능력 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | 4.3 | · | 5.8 | 5.7 | 6.3 | · | 2.9 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 4.2 | |
| Quick Ratio | 2.7 | 1.9 | · | 2.9 | 2.7 | 3.2 | · | 1.2 | 0.4 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 1.6 | |
| Debt / Equity | 1.7 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | 3.3 | 2.1 | · | 1.8 | 1.4 | 2.0 | · | 0.7 | |
| LT Debt / Equity | 1.7 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | 1.2 | 0.7 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 1.6 | · | -12.3 | -10.2 | -8.3 | · | -4.9 |
효율성 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.3 | · | 0.4 | 0.9 | 0.4 | · | 0.4 | 0.5 | 0.4 | · | · | |
| Receivables Turnover | 1.7 | 1.0 | · | 1.7 | 1.0 | 1.0 | · | 1.7 | 1.0 | 1.5 | · | 1.3 | 1.5 | 1.0 | · | 1.1 |
가치 평가 (TTM) 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $762M | $750M | · | $888M | $912M | $1.07B | · | $1.12B | $1.16B | $1.07B | · | $1.10B | $1.07B | $977M | · | $1.52B | |
| Net Income TTM | $-134M | $114M | · | $222M | $-112M | $-91M | · | $-423M | $-799M | $-702M | · | $-778M | $-602M | $-393M | · | $48M | |
| Market Cap | $430M | $430M | · | $465M | $343M | $265M | · | $452M | $361M | $133M | · | $176M | $381M | $522M | · | $1.05B | |
| Enterprise Value | $872M | $843M | · | $882M | $743M | $781M | · | $965M | $1.57B | $1.42B | · | $1.36B | $1.65B | $2.44B | · | $1.88B | |
| P/E | -3.1 | 4.3 | · | 2.2 | -2.7 | -2.5 | · | -1.0 | -0.4 | -0.2 | · | -0.2 | -0.6 | -1.3 | · | 30.0 | |
| P/S | 0.6 | 0.6 | · | 0.5 | 0.4 | 0.2 | · | 0.4 | 0.3 | 0.1 | · | 0.2 | 0.4 | 0.5 | · | 0.7 | |
| P/B | 1.3 | 0.8 | · | 0.8 | 0.6 | 0.5 | · | 0.9 | 0.9 | 0.2 | · | 0.3 | 0.4 | 0.4 | · | 0.7 | |
| P / Tangible Book | 5.4 | 8.2 | · | 3.6 | 5.1 | 3.9 | · | · | · | 1.2 | · | 1.5 | 2.6 | 1.4 | · | 2.1 | |
| P / Cash Flow | · | -12.7 | · | · | · | -23.6 | · | · | · | -2.1 | · | · | · | -2.8 | · | · | |
| P / FCF | · | -11.9 | · | · | · | -17.9 | · | · | · | -1.8 | · | · | · | -2.6 | · | · | |
| EV / EBITDA | -7.0 | 24.8 | · | 11.5 | 464.4 | 10.4 | · | 15.0 | -7.7 | 21.0 | · | -5.6 | -5.6 | -21.5 | · | -44.8 | |
| EV / FCF | · | -23.3 | · | · | · | -52.8 | · | · | · | -19.3 | · | · | · | -12.3 | · | · | |
| EV / Revenue | 1.1 | 1.1 | · | 1.0 | 0.8 | 0.7 | · | 0.9 | 1.3 | 1.3 | · | 1.2 | 1.5 | 2.5 | · | 1.2 | |
| Earnings Yield | -32.6% | 23.5% | · | 44.7% | -36.8% | -40.3% | · | -98.6% | -226.5% | -544.7% | · | -449.7% | -162.7% | -75.9% | · | 3.3% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 | |
|---|---|---|---|---|---|
| 매출 | $743M | $1.04B | $1.05B | $1.12B | — |
| 매출 총이익률 % | — | — | 30.3% | 34.3% | — |
| 영업이익률 % | 13.5% | -10.4% | -69.2% | -15.2% | — |
| 순이익 | $53M | $-191M | $-760M | $-212M | — |
| 희석 EPS | $0.93 | $-3.60 | $-14.85 | $-4.22 | — |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | 1.1 | 1.4 | 2.0 | — | — |
| 유동비율 | 5.0 | 3.7 | 1.0 | — | — |
| 당좌 비율 | 2.2 | 1.6 | 0.5 | — | — |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $157M | $36M | $-258M | $-150M | — |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 212개의 제출자 · $262.9M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 36 (-2 이전 분기 대비) | 24 (+1 이전 분기 대비) | 65 (+2 이전 분기 대비) | 61 (+6 이전 분기 대비) | -78K |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | $24,599,540 | 2,935,506 | 9.36% | 주식 |
| STATE STREET CORP | $24,556,367 | 2,929,238 | 9.34% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $23,216,354 | 2,770,448 | 8.83% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $18,426,271 | 2,198,839 | 7.01% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $10,062,629 | 1,200,791 | 3.83% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $9,567,235 | 1,141,339 | 3.64% | 주식 |
| OAK HILL ADVISORS LP | $9,329,772 | 1,113,338 | 3.55% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $8,984,910 | 1,072,185 | 3.42% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8,626,129 | 1,029,371 | 3.28% | 주식 |
| Prescott Group Capital Management, L.L.C. | $6,475,821 | 772,771 | 2.46% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $5,725,610 | 683,247 | 2.18% | 주식 |
| PRUDENTIAL FINANCIAL INC | $5,719,308 | 682,495 | 2.18% | 주식 |
| D. E. Shaw & Co., Inc. | $5,572,440 | 664,969 | 2.12% | 주식 |
| GOLDMAN SACHS GROUP INC | $4,591,829 | 547,951 | 1.75% | 주식 |
| Allianz Asset Management GmbH | $4,556,885 | 543,781 | 1.73% | 주식 |
| PALISADE CAPITAL MANAGEMENT, LP | $4,316,191 | 515,059 | 1.64% | 주식 |
| NEW YORK STATE COMMON RETIREMENT FUND | $4,306,516 | 513,904 | 1.64% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $4,091,820 | 488,284 | 1.56% | 주식 |
| VANGUARD GROUP INC | $4,091,457 | 331,024 | 1.56% | 주식 |
| Prosight Management, LP | $3,854,398 | 459,952 | 1.47% | 주식 |
| Trexquant Investment LP | $3,753,050 | 447,858 | 1.43% | 주식 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $3,690,745 | 440,423 | 1.40% | 주식 |
| Connor, Clark & Lunn Investment Management Ltd. | $2,966,378 | 353,983 | 1.13% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $2,863,614 | 341,720 | 1.09% | 주식 |
| PANAGORA ASSET MANAGEMENT INC | $2,757,523 | 329,060 | 1.05% | 주식 |
| Values First Advisors, Inc. | $2,526,468 | 301,488 | 0.96% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,420,144 | 288,800 | 0.92% | 콜 옵션 |
| GLOBEFLEX CAPITAL L P | $2,022,077 | 241,298 | 0.77% | 주식 |
| FMR LLC | $1,790,865 | 213,707 | 0.68% | 주식 |
| Brandywine Global Investment Management, LLC | $1,610,632 | 130,310 | 0.61% | 주식 |
| DEUTSCHE BANK AG\ | $1,591,513 | 189,918 | 0.61% | 주식 |
| Morse Asset Management, Inc | $1,536,339 | 183,334 | 0.58% | 주식 |
| WOLVERINE ASSET MANAGEMENT LLC | $1,465,939 | 174,933 | 0.56% | 주식 |
| Y-Intercept (Hong Kong) Ltd | $1,390,066 | 165,879 | 0.53% | 주식 |
| ARISTEIA CAPITAL, L.L.C. | $1,355,490 | 161,753 | 0.52% | 주식 |
| Squarepoint Ops LLC | $1,240,374 | 148,016 | 0.47% | 주식 |
| CREDIT AGRICOLE S A | $1,225,994 | 146,300 | 0.47% | 주식 |
| FRANKLIN RESOURCES INC | $1,140,518 | 136,100 | 0.43% | 주식 |
| Bank of New York Mellon Corp | $1,107,082 | 132,110 | 0.42% | 주식 |
| BANK OF AMERICA CORP /DE/ | $1,038,232 | 123,894 | 0.39% | 주식 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1,028,000 | 122,700 | 0.39% | 주식 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $946,647 | 112,965 | 0.36% | 주식 |
| SILVER OAK SECURITIES, INCORPORATED | $929,024 | 110,862 | 0.35% | 주식 |
| CITADEL ADVISORS LLC | $850,570 | 101,500 | 0.32% | 콜 옵션 |
| Soviero Asset Management, LP | $838,000 | 100,000 | 0.32% | 주식 |
| MACKENZIE FINANCIAL CORP | $817,151 | 97,512 | 0.31% | 주식 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $810,346 | 96,700 | 0.31% | 주식 |
| Cetera Investment Advisers | $807,002 | 96,301 | 0.31% | 주식 |
| UBS Group AG | $801,765 | 95,676 | 0.31% | 주식 |
| SEGALL BRYANT & HAMILL, LLC | $797,818 | 95,205 | 0.30% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $785,206 | 93,700 | 0.30% | 풋 옵션 |
| Sanctuary Advisors, LLC | $746,800 | 89,117 | 0.28% | 주식 |
| MORGAN STANLEY | $734,281 | 87,623 | 0.28% | 주식 |
| MARTINGALE ASSET MANAGEMENT L P | $656,205 | 78,306 | 0.25% | 주식 |
| EVOLVE PRIVATE WEALTH, LLC | $592,801 | 70,740 | 0.23% | 주식 |
| TWO SIGMA ADVISERS, LP | $561,144 | 45,400 | 0.21% | 주식 |
| RHUMBLINE ADVISERS | $560,997 | 66,946 | 0.21% | 주식 |
| Man Group plc | $557,496 | 66,527 | 0.21% | 주식 |
| JANE STREET GROUP, LLC | $552,242 | 65,900 | 0.21% | 콜 옵션 |
| LPL Financial LLC | $543,828 | 64,896 | 0.21% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $539,334 | 64,980 | 0.21% | 주식 |
| Susquehanna Portfolio Strategies, LLC | $529,624 | 63,201 | 0.20% | 주식 |
| CITIGROUP INC | $527,219 | 62,914 | 0.20% | 주식 |
| JAMES INVESTMENT RESEARCH, INC. | $519,250 | 61,963 | 0.20% | 주식 |
| CITADEL ADVISORS LLC | $506,990 | 60,500 | 0.19% | 풋 옵션 |
| Palumbo Wealth Management LLC | $490,557 | 58,539 | 0.19% | 주식 |
| IEQ CAPITAL, LLC | $488,152 | 58,252 | 0.19% | 주식 |
| Assenagon Asset Management S.A. | $473,093 | 56,455 | 0.18% | 주식 |
| Mariner, LLC | $467,769 | 55,817 | 0.18% | 주식 |
| FEDERATED HERMES, INC. | $461,621 | 55,086 | 0.18% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $416,939 | 49,754 | 0.16% | 주식 |
| Vanguard Global Advisers, LLC | $407,888 | 48,674 | 0.16% | 주식 |
| Advantage Alpha Capital Partners LP | $405,156 | 45,936 | 0.15% | 주식 |
| Rafferty Asset Management, LLC | $397,463 | 47,430 | 0.15% | 주식 |
| WINTON GROUP Ltd | $383,335 | 45,744 | 0.15% | 주식 |
| Quantinno Capital Management LP | $375,784 | 44,843 | 0.14% | 주식 |
| ExodusPoint Capital Management, LP | $367,731 | 43,882 | 0.14% | 주식 |
| TRUIST FINANCIAL CORP | $365,966 | 43,671 | 0.14% | 주식 |
| WOLVERINE TRADING, LLC | $353,130 | 39,500 | 0.13% | 풋 옵션 |
| Brevan Howard Capital Management LP | $326,116 | 38,916 | 0.12% | 주식 |
| Integrated Quantitative Investments LLC | $322,638 | 38,501 | 0.12% | 주식 |
| CANADA PENSION PLAN INVESTMENT BOARD | $292,462 | 34,900 | 0.11% | 주식 |
| Cambria Investment Management, L.P. | $285,247 | 34,039 | 0.11% | 주식 |
| CWM, LLC | $280,017 | 33,737 | 0.11% | 주식 |
| ENVESTNET ASSET MANAGEMENT INC | $278,392 | 33,221 | 0.11% | 주식 |
| WOLVERINE TRADING, LLC | $272,670 | 30,500 | 0.10% | 콜 옵션 |
| OPPENHEIMER ASSET MANAGEMENT INC. | $265,202 | 31,647 | 0.10% | 주식 |
| MetLife Investment Management, LLC | $250,839 | 29,933 | 0.10% | 주식 |
| Keystone Financial Group | $238,730 | 28,488 | 0.09% | 주식 |
| BANK OF MONTREAL /CAN/ | $229,847 | 27,428 | 0.09% | 주식 |
| BlackRock, Inc. | $225,045 | 26,855 | 0.09% | 주식 |
| MERCER GLOBAL ADVISORS INC /ADV | $221,391 | 26,419 | 0.08% | 주식 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $216,237 | 25,804 | 0.08% | 주식 |
| WOLVERINE TRADING, LLC | $208,928 | 23,370 | 0.08% | 주식 |
| State of Wyoming | $203,408 | 24,273 | 0.08% | 주식 |
| PROFUND ADVISORS LLC | $202,360 | 24,148 | 0.08% | 주식 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $198,054 | 24,603 | 0.08% | 주식 |
| Glenmede Investment Management, LP | $183,438 | 20,798 | 0.07% | 주식 |
| Graham Capital Management, L.P. | $180,941 | 21,592 | 0.07% | 주식 |
| DIVERSIFIED TRUST CO | $173,625 | 20,719 | 0.07% | 주식 |
회사 내부자 47 명의 내부자 · 10 임원 · 5 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Daniel Abdun-Nabi | Chief Executive Officer | 2018년 6월 5일 S | 197,343 | 0 | 0 | $0 |
| Richard S Lindahl | EVP, Chief Financial Officer | 2026년 6월 8일 F | 374,083 | 0 | 0 | $0 |
| Don R Elsey | Chief Financial Officer | 2012년 3월 13일 A | 26,614 | 0 | 0 | $0 |
| Paul Anthony Williams | SVP, Products Business | 2026년 7월 1일 S | 159,098 | 0 | 1 | $-25,200 |
| William Hartzel | SVP, Bioservices | 2026년 6월 8일 F | 185,558 | 0 | 0 | $0 |
| Coleen Glessner | EVP, Quality & Ethics, and CPL | 2026년 6월 8일 F | 202,201 | 0 | 0 | $0 |
| Barry Labinger | EVP, Biosciences Div. | 2015년 11월 13일 S | 25,182 | 0 | 0 | $0 |
| Steven Chatfield | EVP, BioSciences | 2013년 3월 14일 F | 28,000 | 0 | 0 | $0 |
| Kyle Keese | EVP, BioSciences Division | 2011년 3월 15일 A | 18,759 | 0 | 0 | $0 |
| Stephen Lockhart | SVP Product Development | 2010년 11월 11일 M | 6,980 | 0 | 0 | $0 |
| John D Fowler JR | 이사 | 2026년 4월 30일 A | 30,350 | 0 | 0 | $0 |
| Fuad El-Hibri | 이사 | 2021년 12월 3일 J | 206,434 | 0 | 0 | $0 |
| John Niederhuber | 이사 | 2016년 5월 18일 D | 30,300 | 0 | 0 | $0 |
| Shahzad Malik | 이사 | 2007년 6월 14일 A | — | 0 | 0 | $0 |
| Intervac, L.L.C. | 10% 소유주 | 2012년 9월 18일 J | 4,344,250 | 0 | 0 | $0 |
| BioPharm, L.L.C. | 10% 소유주 | 2010년 5월 27일 J | 2,265,043 | 0 | 0 | $0 |
| Microscience Investments LTD | 10% 소유주 | 2007년 3월 8일 J | 0 | 0 | 0 | $0 |
| Zsolt Harsanyi | — | 2026년 4월 30일 A | 149,076 | 0 | 0 | $0 |
| Ronald Richard | — | 2026년 4월 30일 A | 123,761 | 0 | 2 | $-263,101 |
| Keith Katkin | — | 2026년 4월 30일 A | 96,294 | 0 | 1 | $-128,183 |
| Joseph C Papa | — | 2026년 4월 29일 A | 493,153 | 0 | 0 | $0 |
| Kathryn C Zoon | — | 2025년 4월 30일 A | 78,885 | 0 | 0 | $0 |
| Donald W Degolyer | — | 2025년 4월 30일 A | 145,503 | 0 | 0 | $0 |
| Sujata Tyagi Dayal | — | 2025년 4월 30일 A | 97,532 | 0 | 0 | $0 |
| Neal Franklin Fowler | — | 2025년 4월 30일 A | 135,503 | 0 | 0 | $0 |
| Marvin L White | — | 2025년 4월 30일 A | 88,495 | 0 | 0 | $0 |
| Louis W Sullivan | — | 2025년 4월 30일 A | 139,098 | 0 | 0 | $0 |
| Simon C Lowry | — | 2025년 3월 6일 A | 91,982 | 0 | 0 | $0 |
| Jessica Perl | — | 2025년 3월 6일 A | 68,387 | 0 | 0 | $0 |
| Jennifer Lynne Fox | — | 2024년 7월 11일 A | 186,382 | 0 | 0 | $0 |
| Adam Havey | — | 2023년 6월 9일 A | 174,398 | 0 | 0 | $0 |
| Robert Kramer | — | 2023년 6월 9일 A | 506,059 | 0 | 0 | $0 |
| Jerome M Hauer | — | 2023년 5월 25일 A | 57,508 | 0 | 0 | $0 |
| Katherine Strei | — | 2023년 2월 28일 F | 62,824 | 0 | 0 | $0 |
| Atul Saran | — | 2023년 2월 28일 F | 86,645 | 0 | 0 | $0 |
| George A Joulwan | — | 2022년 5월 26일 A | 40,244 | 0 | 0 | $0 |
| Karen L. Smith | — | 2021년 5월 7일 F | 11,888 | 0 | 0 | $0 |
| Sean Kirk | — | 2021년 3월 31일 F | 17,776 | 0 | 0 | $0 |
| Sue Bailey | — | 2021년 3월 4일 S | 24,427 | 0 | 0 | $0 |
| Denise Esposito | — | 2009년 3월 10일 A | 500 | 0 | 0 | $0 |
| Biologika, L.L.C. | — | 2008년 6월 4일 S | 1,399,764 | 0 | 0 | $0 |
| Joe M Allbaugh | — | 2008년 5월 21일 A | — | 0 | 0 | $0 |
| Michigan Biologic Products, Inc. | — | 2008년 3월 28일 S | 1,269,390 | 0 | 0 | $0 |
| Mauro Gibellini | — | 2007년 6월 4일 S | 0 | 0 | 0 | $0 |
| Thomas Zink | — | 2007년 5월 17일 P | 1,000 | 0 | 0 | $0 |
| Edward Arcuri | — | 2007년 5월 8일 M | 76,722 | 0 | 0 | $0 |
| Robert Calvin Myers | — | 2006년 11월 20일 C | — | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 1 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Emergent BioSolutions Inc. | 2010년 8월 23일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 78 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| FSCC · Federated Hermes ETF Trust | 0.17% | 51,825 NS | 2026년 5월 31일 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0.17% | 18,243 NS | 2026년 5월 31일 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.15% | 91,705 NS | 2026년 4월 30일 | N-PORT |
| CALF · Pacer Funds Trust | 0.10% | 412,173 NS | 2026년 4월 30일 | N-PORT |
| FNDA · SCHWAB STRATEGIC TRUST | 0.08% | 757,640 NS | 2026년 5월 31일 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0.08% | 2,270,234 NS | 2026년 5월 31일 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.06% | 67,946 NS | 2026년 5월 31일 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.03% | 98,804 NS | 2026년 5월 31일 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.03% | 283,798 NS | 2026년 4월 30일 | N-PORT |
| TMFX · RBB Fund, Inc. | 0.02% | 845 NS | 2026년 5월 31일 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.02% | 372,675 NS | 2026년 4월 30일 | N-PORT |
| RSSL · Global X Funds | 0.01% | 22,630 NS | 2026년 4월 30일 | N-PORT |
| EBI · RBB Fund Trust | 0.01% | 8,994 NS | 2026년 5월 31일 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 2,456 NS | 2026년 5월 31일 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 170,332 NS | 2026년 4월 30일 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.01% | 247,675 NS | 2026년 5월 31일 | N-PORT |
| UWM · ProShares Trust | 0.01% | 1,920 NS | 2026년 5월 31일 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0.01% | 9,376 NS | 2026년 5월 31일 | N-PORT |
| URTY · ProShares Trust | 0.01% | 1,941 NS | 2026년 5월 31일 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 39,744 NS | 2026년 5월 31일 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2,138 NS | 2026년 5월 31일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 140,649 NS | 2026년 4월 30일 | N-PORT |
| HDG · ProShares Trust | 0.00% | 49 NS | 2026년 5월 31일 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0.00% | 911 NS | 2026년 5월 31일 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 2,661 NS | 2026년 4월 30일 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 18,981 NS | 2026년 4월 30일 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 10,026 NS | 2026년 4월 30일 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 2,677 NS | 2026년 4월 30일 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 30,279 NS | 2026년 5월 31일 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 8 NS | 2026년 4월 30일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VXUS · VANGUARD STAR FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | — | — | 2026년 7월 15일 | 일간 |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | — | — | 2026년 7월 15일 | 일간 |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | — | — | 2026년 7월 15일 | 일간 |
| VEA · VANGUARD TAX-MANAGED FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VYMI · VANGUARD WHITEHALL FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| IEV · iShares Trust | — | — | 2026년 7월 13일 | 일간 |
| ITOT · iShares Trust | — | — | 2026년 8월 5일 | 일간 |
| IWV · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IWN · iShares Trust | — | — | 2026년 8월 17일 | 일간 |
| IWM · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IBB · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IXG · iShares Trust | — | — | 2026년 8월 3일 | 일간 |
| IWC · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 2026년 7월 13일 | 일간 |